“Is the open mouth mightier than the needle?” Dr. Peter Martin on Ibrutinib for MCL Patients

In the latest issue of Blood, Dr. Peter Martin writes about the latest use of ibrutinib for patients with mantle cell lymphoma.



Post a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s